30 related articles for article (PubMed ID: 30815926)
1. 14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology.
Asciutto KC; Borgfeldt C; Forslund O
BMC Cancer; 2020 Oct; 20(1):1025. PubMed ID: 33097006
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study.
Ren C; Zhu Y; Yang L; Zhang X; Liu L; Wang Z; Jiang D
Virol J; 2019 Nov; 16(1):143. PubMed ID: 31752941
[TBL] [Abstract][Full Text] [Related]
3. HPV16 E7 oncoprotein test as a triage strategy for HPV16-positive women in cervical cancer screening: long-term follow-up outcome.
Wang X; Shuai G; Xu J; Liu M; Zhao J; Zhang N; Zhang W; Qu P
Front Oncol; 2023; 13():1221962. PubMed ID: 37795449
[TBL] [Abstract][Full Text] [Related]
4. Effect of Condom Use after CIN Treatment on Cervical HPV Biomarkers Positivity: Prolonged Follow Up Study.
Valasoulis G; Michail G; Pouliakis A; Androutsopoulos G; Panayiotides IG; Kyrgiou M; Daponte A; Paraskevaidis E
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884589
[TBL] [Abstract][Full Text] [Related]
5. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
[TBL] [Abstract][Full Text] [Related]
6. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
Luttmer R; Berkhof J; Dijkstra MG; van Kemenade FJ; Snijders PJ; Heideman DA; Meijer CJ
J Clin Virol; 2015 Jun; 67():59-66. PubMed ID: 25959161
[TBL] [Abstract][Full Text] [Related]
7. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
8. Role of the HPV DNA test in follow-up of treated cervical intraepithelial neoplasia in Bangladesh.
Nessa A; Rashid MH; Jahan M; Ferdous NE; Nahar PA; Chowdhury A
Asian Pac J Cancer Prev; 2014; 15(19):8063-7. PubMed ID: 25338985
[TBL] [Abstract][Full Text] [Related]
9. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
10. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
Zhang H; Varma KR; Han M; Matsko J; Zhao C
Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
[TBL] [Abstract][Full Text] [Related]
11. Role of HPV DNA, HPV mRNA and cytology in the follow-up of women treated for cervical dysplasia.
Tisi G; Gargiulo F; Gozzini E; Baronchelli C; Odicino F; Salinaro F; Sartori E; Caruso A; Facchetti F; De Francesco MA
APMIS; 2019 Apr; 127(4):196-201. PubMed ID: 30815926
[TBL] [Abstract][Full Text] [Related]
12. Aptima HPV messenger RNA testing and histopathologic follow-up in women with HSIL cytology: A study emphasizing additional review of HPV-negative cases.
Li A; Li J; Austin RM; Wang T; Ashman D; Zhang H; Matsko J; Zhao C
Cancer Cytopathol; 2021 Aug; 129(8):622-631. PubMed ID: 33764649
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
